Health and Life Sciences Firms Told to Govern AI Costs Before Scaling
Global – – October 15, 2026 -- Only 17% of health and life sciences leaders report a centralized approach to internal data governance, according to 2026 Voice of Our Clients (VOC) research, even as organizations move generative AI from pilots into production.
Data governance gaps widen across partner ecosystems
The VOC research found that 54% of the health and life sciences business and IT leaders interviewed have a holistic data strategy across their internal enterprise. Across external ecosystems of partners and suppliers, the share with a holistic strategy falls to 32%, and the share with centralized data governance falls to 14%.
Enterprise AI depends on trusted data and governance that extends beyond individual experiments, so these gaps limit how far AI programs can scale.